secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2021-09-08T23:59:59+00:00
Accession:  0001193125-21-267387
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical to acquire Smiths Medical for $2.35B in cash and stock; expected close H1 2022
--------------------------------------------------------------------------------

- Total consideration: $1.85B cash, 2.5M ICUI shares (~$500M), plus up to $100M earn-out based on stock price.
- Combination creates ~$2.5B pro forma revenue infusion therapy company; Smiths to own ~10% of ICUI post-close.
- Smiths gains board seat if it holds ≥5% of ICUI; shares subject to 6-month lock-up and standstill restrictions.
- Transaction subject to antitrust, FDI approvals, and Smiths' French works council consultation; long-stop date undefined.
- $2B senior secured credit facilities committed by Wells Fargo and Barclays to fund cash portion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000119312521267387/0001193125-21-267387-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000119312521267387/d228927d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-267387

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer